Skip to main content

Separator

73 courses availables

COR2ED Trainingdottime30 min

Code of Conduct Assessment

cor2ed
Onco-geneticsdottime30 min

Diagnosis and treatment of TRK fusion-positive lung cancer

eaccme EACCME®
Onco-geneticsdottime60 min

Diagnosing and treating TRK fusion-positive cancer

eaccme EACCME®
Onco-geneticsdottime60 min

TRK fusion-positive sarcomas and lung cancer

eaccme EACCME®
Onco-geneticsdottime60 min

Current opinions on how to identify, test and treat NTRK fusion positive cancer

eaccme EACCME®
Onco-geneticsdottime60 min

The Role of PARP Inhibition in Prostate Cancer

eaccme EACCME®
Onco-geneticsdottime60 min

The Role of PARP inhibition in Clinical Practice

eaccme EACCME®
Cardiologydottime60 min

Management of Patients with Acute Coronary Syndrome (ACS)

eaccme EACCME®
Cardiologydottime60 min

Improving management through genetic testing for Familial Hypercholesterolaemia (FH)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Проявления кожной токсичности, связанные с таргетной терапией рака ЖКТ и печени (RU)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

胃腸および肝臓腫瘍に対する標的療法に関連する皮膚毒性 (JA)

eaccme EACCME®
Gastrointestinal Oncologydottime30 min

Long term management of advanced colorectal cancer

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Exploring the current gastroesophageal cancer treatment landscape and near-future developments

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Toxicidades cutáneas relacionadas con la terapia dirigida en oncología hepática y gastrointestinal (ES)

eaccme EACCME®accme ACCMEabim ABIM
Gastrointestinal Oncologydottime60 min

Marco de Comunicación GUIDE (ES)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Skin Toxicities Related to Targeted Therapy in GI and Liver Oncology

eaccme EACCME®accme ACCMEabim ABIM
Gastrointestinal Oncologydottime60 min

Impact of TRIBE-2, Re-ARRANGE and FOxTROT data in colorectal cancer on sequential clinical practice

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

GUIDE Communication Framework

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

How long should treatment of colorectal cancer be within an adjuvant setting: 3 or 6 months?

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

The SHARE 5 Step Communication Framework for Shared Decision-Making in 3rd-Line Treatment of Metastatic Colorectal Cancer (mCRC)

eaccme EACCME®
Gastrointestinal Oncologydottime60 min

Treatment Sequencing and Flexible Dosing in Later-Line Management of Colorectal Cancer

eaccme EACCME®
Genitourinary Oncologydottime30 min

Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgens

Module 2 of 2
eaccme EACCME®
Genitourinary Oncologydottime30 min

PARP inhibitors in Advanced Prostate Cancer

Module 1 of 2
eaccme EACCME®
Genitourinary Oncologydottime60 min

Incorporating PARP inhibitors into prostate cancer clinical practice

eaccme EACCME®
Genitourinary Oncologydottime60 min

Targeting advanced prostate cancer with PARP inhibitors: Who, When and How?

eaccme EACCME®
Genitourinary Oncologydottime60 min

PARP inhibitors in Prostate Cancer

eaccme EACCME®
Genitourinary Oncologydottime30 min

Radiopharmaceuticals in prostate cancer

Episode 1: radium-223
eaccme EACCME®
Genitourinary Oncologydottime30 min

Radiopharmaceuticals in prostate cancer

Episode 2: PSMA Theranostics
eaccme EACCME®
Genitourinary Oncologydottime60 min

Current opinions on managing nmCRPC and the implications of new imaging modalities

eaccme EACCME®
Genitourinary Oncologydottime60 min

The SHARE Communication Framework Supporting Physicians In Shared Decision-Making With Patients Treated For Metastatic Castration Resistant Prostate Cancer (mCRPC)

eaccme EACCME®
Genitourinary Oncologydottime60 min

Treatment sequencing for mCRPC patients within the changing landscape of mHSPC

eaccme EACCME®
Genitourinary Oncologydottime60 min

New Therapies for mHSPC

eaccme EACCME®
Liver Oncologydottime60 min

Treatment options for HCC patients who are not eligible for or progressed on IO

Clinical considerations and when to switch
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 2: in-depth subgroup analyses and challenges
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 1: efficacy and safety
eaccme EACCME®
Liver Oncologydottime60 min

1st line monotherapy in advanced or unresectable HCC

eaccme EACCME®
Liver Oncologydottime60 min

Appropriate selection of patients for combination immunotherapy in HCC: the now and the next

eaccme EACCME®
Liver Oncologydottime60 min

Treatment sequencing in advanced hepatocellular carcinoma

eaccme EACCME®
Liver Oncologydottime60 min

Understanding the changing treatment landscape in hepatocellular carcinoma and optimising therapy for the individual patient

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICU

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

NICU和PICU的血气和经皮监测 (CN)

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

Blutgase und Transkutanes Monitoring in der NICU und der PICU (DE)

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

Gases en Sangre y Monitorización Transcutánea en UCIN y UCIP (ES)

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

Gaz du sang et monitorage transcutané en soins intensifs néonatals et pédiatriques (FR)

eaccme EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICUdottime60 min

NICU と PICU における血液ガスと経皮モニタリング コースの説明 (JA)

eaccme EACCME®
Neuroendocrine Tumoursdottime30 min

Recognising, Diagnosing and Managing Neuroendocrine Tumours

eaccme EACCME®
Neuroendocrine Tumoursdottime30 min

The role of SSA at progression

eaccme EACCME®
Neuroendocrine Tumoursdottime60 min

Treatment sequencing in advanced digestive NET

eaccme EACCME®
Neuroendocrine Tumoursdottime60 min

Treatment Developments for Neuroendocrine Tumours

eaccme EACCME®
Hemato-oncologydottime60 min

Chemotherapy-free treatment approaches in lymphoma

eaccme EACCME®
Hemato-oncologydottime60 min

Update on follicular lymphoma

eaccme EACCME®
Hemostasisdottime60 min

Managing thrombosis: podcast series

eaccme EACCME®
Hemostasisdottime60 min

Normalising Haemostasis in Haemophilia - A new standard of care

eaccme EACCME®
Hemostasisdottime30 min

Von Willebrand disease in the emergency care setting

eaccme EACCME®
Hemostasisdottime30 min

Frauen mit Blutungsneigungen (DE)

Modul 1 - Wie man Blutungsneigungen bei Frauen und Mädchen erkennt
eaccme EACCME®
Hemostasisdottime30 min

出血性疾患がある女性 (JA)

モジュ - ル1–女性および少女の出血性疾患を認識する方法
eaccme EACCME®
Hemostasisdottime30 min

Frauen mit Blutungsneigungen (DE)

Modul 2 - Diagnostik und Behandlung von Frauen mit Blutungsneigungen
eaccme EACCME®
Hemostasisdottime30 min

出血性疾患がある女性 (JA)

モジュ - ル2を完了すると、次のようになります
eaccme EACCME®
Hemostasisdottime30 min

Mujeres con Trastornos Hemorrágicos (ES)

Módulo 1 - ¿Cómo reconocer y detectar trastornos hemorrágicos en mujeres y niñas?
eaccme EACCME®
Hemostasisdottime30 min

Mujeres con Trastornos Hemorrágicos (ES)

Módulo 2 - Cómo diagnosticar y tratar a mujeres con trastornos hemorrágicos
eaccme EACCME®
Hemostasisdottime30 min

Les troubles de la coagulation chez la femme (FR)

Module 1 – Comment identifier les troubles de la coagulation chez les femmes et les filles
eaccme EACCME®
Hemostasisdottime30 min

Les troubles de la coagulation chez la femme (FR)

Module 2 - Comment diagnostiquer et traiter les femmes qui souffrent de troubles de la coagulation
eaccme EACCME®
Hemostasisdottime30 min

How to care for a patient with von Willebrand disease

Module 3 of 3
eaccme EACCME®
Hemostasisdottime30 min

How to screen for von Willebrand disease

Module 2 of 3
eaccme EACCME®
Hemostasisdottime30 min

When to consider von Willebrand disease

Module 1 of 3
eaccme EACCME®
Hemostasisdottime30 min

Women with Bleeding Disorders

Module 1 – How to recognise bleeding disorders in women and girls
eaccme EACCME®
Hemostasisdottime30 min

Women with Bleeding Disorders

Module 2 - How to diagnose and manage women with bleeding disorders
eaccme EACCME®
Hemostasisdottime60 min

Practical considerations around the use of TPO-RAs in ITP

eaccme EACCME®
Endocrinologydottime60 min

Current perspectives on childhood growth disorders

eaccme EACCME®
Bone Diseasesdottime60 min

ASBMR 2021 Rare Bone Disease Highlights

eaccme EACCME®
Sarcomadottime30 min

Diagnosis and Management approach for Bone Sarcoma

eaccme EACCME®
Pediatricsdottime30 min

Addressing diagnostic challenges of Severe Primary IGF-I Deficiency

eaccme EACCME®
Breast Cancerdottime60 min

New oral endocrine therapy options for patients with advanced or metastatic ER+ breast cancer

eaccme EACCME®